Phacilitate 2012 Cell & Gene Therapy Forum

30 JAN–1 FEB 2012

Phacilitate's Cell & Gene Therapy Forum provides a highly valuable meeting place for senior level figures driving the transition of these technologies into safe, commercially-viable products.
From promise to products, the programme covers:

• Cell therapy
• Gene therapy
• Tissue engineering

This year David James, Invetech Director, Life Science and Pharmaceutical, in conjunction with key industry leaders, will conduct a Breakfast workshop outlining Cell Therapy commercialisation and ask the question, Cell therapies — are we finally closing the gap? The session will provide attendees with valuable insight into the exciting cell therapy industry and hear first-hand how some of the commercialization challenges are being addressed.

Session details:
Breakfast Briefing DAY 2
Tuesday January 31st 2012 at 7.45am

Phacilitate 2012
Cell & Gene Therapy Forum
The Grand Hyatt
Washington DC

For more information go to http://www.phacilitate.co.uk/cgt